Cortigent presents 6-year study results for vision implant device Jan 29, 2026 07:30AM
Vivani Medical withdraws Cortigent spin-off record date due to government shutdown Oct 3, 2025 08:30AM
H.C. Wainwright Reiterates Buy Rating on Vivani Medical, Inc. (VANI) Sep 5, 2025 06:48AM
Vivani Medical plans phase 1 trial for semaglutide implant NPM-139 Sep 4, 2025 08:30AM
Vivani Medical, Inc. (VANI) Misses Q2 EPS by 2c Aug 13, 2025 06:16PM


Aug 13, 2025 04:20PM Vivani Medical secures $10M equity financing for semaglutide implant
Jun 11, 2025 08:02AM Vivani Medical (VANI) Appoints Anthony Baldor as CFO
May 29, 2025 08:31AM Vivani Medical (VANI) Files Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
May 13, 2025 06:25PM Vivani Medical, Inc. (VANI) Misses Q1 EPS by 1c
Apr 15, 2025 08:31AM Vivani Medical (VANI) and Okava Expand Collaboration to Develop OKV-119
Apr 4, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Vivani Medical, Inc. (VANI)
Mar 31, 2025 08:11AM Vivani Medical, Inc. (VANI) Reports In-Line Q4 EPS
Mar 27, 2025 07:34AM Vivani Medical (VANI) Announces 7.37M Share Offering at $1.12/sh
Mar 27, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Vivani Medical, Inc. (VANI)
Mar 26, 2025 07:30AM Vivani Medical (VANI) Announces Positive Preclinical Weight Loss Data for NPM-139
Mar 13, 2025 07:31AM Vivani Medical (VANI) Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
Mar 13, 2025 06:48AM H.C. Wainwright Reiterates Buy Rating on Vivani Medical, Inc. (VANI)
Mar 12, 2025 08:30AM Vivani Medical (VANI) to Spin Off Cortigent Neurostimulation Business
Dec 23, 2024 07:11AM H.C. Wainwright Reiterates Buy Rating on Vivani Medical, Inc. (VANI)
Dec 19, 2024 08:31AM Vivani Medical (VANI) Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Sep 26, 2024 08:31AM Vivani Medical (VANI) Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
Sep 4, 2024 08:05AM Vivani Medical (VANI) Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant
Aug 13, 2024 05:55PM Vivani Medical, Inc. (VANI) Tops Q2 EPS by 2c
Jun 13, 2024 08:00AM Vivani Medical (VANI) Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant